Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


To Improve Adverse Event Tracking, FDA Could Google It

Executive Summary

Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.


Related Content

Califf Lowering FDA Drawbridge To Work With External Expertise
FDA Acquires Trove Of Rx Safety Data Through Alliance With PatientsLikeMe
Cosmetic Adverse Event Reports Spiked 56% In Fiscal 2014 – FDA
Social Media Guidance Gives Drug Firms A Pass On User Content
Social Media Site Could Help FDA Track Adverse Events
Internet Searching May Get ‘Riskier’ For Patients After FDA Citations



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts